DrugDashboards

pentazocine and naloxone

pentazocine and naloxone · PENTAZOCINE 50 mg/1; NALOXONE HYDROCHLORIDE .5 mg/1 · Tablet · Oral · Sun Pharmaceutical Industries, Inc.

NDC 63304-0506-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA075523
TE code
AB
Approval date
Mar 17, 2000
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of pentazocine and naloxone (Tablet)

LabelerStrengthFirst seenLast seen
Sun Pharmaceutical Industries, Inc.PENTAZOCINE 50 mg/1; NALOXONE HYDROCHLORIDE .5 mg/1Aug 26, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.PENTAZOCINE .5 mg/1; NALOXONE HYDROCHLORIDE 50 mg/1Jul 22, 2026Aug 19, 2026
Sun Pharmaceutical Industries, Inc.NALOXONE HYDROCHLORIDE .5 mg/1; PENTAZOCINE 50 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "pentazocine and naloxone — NDC 63304-0506-01," retrieved September 3, 2026, https://drugdashboards.com/drug/63304050601.

Free to cite with attribution — see how the data is put together.